Genetic Targeting or Pharmacologic Inhibition of NADPH Oxidase Nox4 Provides Renoprotection in Long-Term Diabetic Nephropathy

Jay C. Jha, Stephen P. Gray, David Barit, Jun Okabe, Assam El-Osta, Tamehachi Namikoshi, Vicki Thallas-Bonke, Kirstin Wingler, Cedric Szyndralewiez, Freddy Heitz, Rhian M. Touyz, Mark E. Cooper, Harald H. H. W. Schmidt, Karin A. Jandeleit-Dahm

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1237-1254
JournalJournal of the American Society of Nephrology
Volume25
Issue number6
DOIs
Publication statusPublished - Jun 2014

Cite this

Jha, J. C., Gray, S. P., Barit, D., Okabe, J., El-Osta, A., Namikoshi, T., Thallas-Bonke, V., Wingler, K., Szyndralewiez, C., Heitz, F., Touyz, R. M., Cooper, M. E., Schmidt, H. H. H. W., & Jandeleit-Dahm, K. A. (2014). Genetic Targeting or Pharmacologic Inhibition of NADPH Oxidase Nox4 Provides Renoprotection in Long-Term Diabetic Nephropathy. Journal of the American Society of Nephrology, 25(6), 1237-1254. https://doi.org/10.1681/ASN.2013070810